BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37516650)

  • 1. The Naples prognostic score in esophagus cancer: Prognostic and beyond.
    Demir M; Demircan NC
    Bull Cancer; 2023 Oct; 110(10):1027-1040. PubMed ID: 37516650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.
    Hurmuzlu M; Øvrebø K; Monge OR; Smaaland R; Wentzel-Larsen T; Viste A
    World J Surg Oncol; 2010 Jun; 8():46. PubMed ID: 20515502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy.
    Demir M; Demircan NC
    Saudi J Gastroenterol; 2023; 29(2):119-126. PubMed ID: 36412459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy.
    Liu J; Wang Z; Liu G; Liu Z; Lu H; Ji S
    Ann Med; 2023; 55(2):2242254. PubMed ID: 37552770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study.
    Li Q; Cong R; Wang Y; Kong F; Ma J; Wu Q; Ma X
    Gynecol Oncol; 2021 Jan; 160(1):91-98. PubMed ID: 33081984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive chemoradiation therapy or surgery for clinical T1-3N0-1M0 thoracic esophageal squamous cell carcinoma: A propensity score matching analysis.
    Li XY; Luo HS; Wu SX; Du ZS; Zheng CP; Wu ZY
    Asian J Surg; 2019 Jan; 42(1):350-355. PubMed ID: 29802029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.
    Guo JC; Huang TC; Lin CC; Hsieh MS; Chang CH; Huang PM; Lee JM; Hsu FM; Chia-Hsien Cheng J; Wang HP; Yeh KH; Cheng AL; Hsu CH
    J Thorac Oncol; 2015 Oct; 10(10):1481-9. PubMed ID: 26313683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute.
    Jing W; Guo H; Kong L; Zhang Y; Wang H; An C; Zhu H; Yu J
    Medicine (Baltimore); 2016 Dec; 95(50):e5630. PubMed ID: 27977606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Preoperative Naples Prognostic Score in Patients With Non-Small Cell Lung Cancer.
    Ren D; Wu W; Zhao Q; Zhang X; Duan G
    Technol Cancer Res Treat; 2022; 21():15330338221129447. PubMed ID: 36254549
    [No Abstract]   [Full Text] [Related]  

  • 16. Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.
    Ohira M; Kubo N; Masuda G; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4897-901. PubMed ID: 26254385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).
    Nomura M; Kato K; Ando N; Ohtsu A; Muro K; Igaki H; Abe T; Takeuchi H; Daiko H; Gotoh M; Kataoka K; Wakabayashi M; Kitagawa Y
    Jpn J Clin Oncol; 2017 Jun; 47(6):480-486. PubMed ID: 28334858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
    de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP
    Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative chemoradiotherapy improves survival in esophageal squamous cell cancer with extracapsular lymph node extension.
    Wang ZW; Luan ZP; Zhang W; Dong W; Fu CR; Wang YN; Li BS
    Neoplasma; 2014; 61(6):732-8. PubMed ID: 25150318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.